Given that BDTX has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank ...

Black Diamond Therapeutics, Inc. ( (BDTX)) has released its Q3 earnings. Here is a breakdown of the information Black Diamond Therapeutics, Inc. presented to its investors. Black Diamond ...

With a 36% objective response rate and encouraging durability, BDTX-1535 shows potential to address osimertinib resistance. The Dow Jones closed lower by around 250 points on Thursday. When ...

Black Diamond Therapeutic (NASDAQ:BDTX) just reported results for the second quarter of 2024. Black Diamond Therapeutic reported earnings per share of -36 cents. This was above the analyst ...

Analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Black Diamond Therapeutics (BDTX – Research Report), retaining the price target of $11.00. Robert Burns has given his Buy ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...

San Gabriel Project Completion: Reached 65% overall completion. Compania de Minas Buenaventura SAA (NYSE:BVN) reported a significant increase in EBITDA from direct operations, reaching $132 ...

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces ...